Canada approves the first generic Ozempic
Published October 26, 2026. News from April 28, 2026, as reported by Global News, cited below.
Quick take: Health Canada authorized a generic version of injectable semaglutide made by Dr. Reddy's Laboratories. It says Canada is the first G7 country to do so.
The facts
| Item | Per the report |
|---|---|
| Product | Generic of Ozempic, once weekly, for adults with type 2 diabetes |
| Maker | Dr. Reddy's Laboratories |
| Review | Submitted early 2024, six month target met (clock excludes time waiting on the company) |
| Still in review | Eight other generic semaglutide submissions |
What about price?
Health Canada says generics are often 45% to 90% cheaper than brand versions. Under the pan-Canadian pricing framework, the first generic would cost about 75% to 85% of the brand price, falling to about 50% with a second generic and about 35% with three or more. The report gives no launch date.
Why it matters for peptide readers
This is what the official route looks like: full review, then a Notice of Compliance. See the 5 steps and the market race.
Ready to order?
Paste it in the Promo code box in the order summary at checkout, then press Apply. Confirm the discount line before you pay.
Common questions
Who makes the generic?
Dr. Reddy's Laboratories, per Global News.
Is it on pharmacy shelves?
The report gives no launch date.
Why is it cheaper?
Health Canada's pricing framework sets generics below the brand price, and it falls further as more generics enter.
Sources
- Global News: Health Canada approves first generic Ozempic (Apr 28-29, 2026)
- Health Canada: How drugs are reviewed in Canada
Summarised in my own words. Read the originals for the full detail.